Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SH3D21 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ANLN | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | STX16 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | UBA2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ANGEL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | QRSL1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PIKFYVE | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | EPGN | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | POLE2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |